Clinical Outcomes of Bail-Out Stenting After Drug-Coated Balloon Angioplasty: The International Multicenter BAILOUT Registry
Circulation: Cardiovascular Interventions · 2026
DOI: 10.1161/circinterventions.125.016461 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Interventions, 2026. Verfasst von Mauro Gitto und 43 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy (M. Gitto, G.C., F.T., M.C., D.R., A.M., G.G., B.R., G.G.S., A.C.). Hauptthemen laut MEDLINE: Angioplasty, Balloon, Coronary, Drug-Eluting Stents, Coated Materials, Biocompatible, Coronary Artery Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Drug-coated balloons (DCBs) are increasingly adopted in percutaneous coronary intervention. Bail-out drug-eluting stent (DES) implantation due to suboptimal immediate results after DCB angioplasty is not infrequent, and the clinical outcomes of percutaneous coronary intervention with DCB angioplasty followed by bail-out DES implantation remain unexplored. The aim of this study was to evaluate the safety of bail-out DES implantation following DCB angioplasty in percutaneous coronary intervention. METHODS: The BAILOUT registry included consecutive patients undergoing bail-out DES implantation after DCB angioplasty at 17 European centers between 2011 and 2024. The primary end point was target lesion failure (TLF) at 1 year, defined as the composite of target lesion revascularization, target vessel myocardial infarction, and cardiac death. The TLF rate was compared with a performance goal of 7.0% for an upfront DES-only strategy, derived from a meta-analysis of contemporary randomized controlled trials. RESULTS: A total of 733 patients were included, accounting for 5.5% of all DCB-based percutaneous coronary interventions. At 1 year, the cumulative TLF incidence in the overall population was 7.0% (95% CI, 5.2%–9.3%), which was comparable to the performance goal ( P =0.916). This was mainly driven by target lesion revascularization (4.1%), while cardiac death and target vessel myocardial infarction occurred both in 1.9% of patients. The incidence of stent thrombosis was 0.6%. Independent predictors of 1-year TLF included lesion length (hazard ratio, 1.02 per mm increase [95% CI, 1.01–1.03]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy (M. Gitto, G.C., F.T., M.C., D.R., A.M., G.G., B.R., G.G.S., A.C.).
- Department of Biomedical Sciences; Humanitas University; Pieve Emanuele-Milan, Italy (M. Gitto, G.C., F.T., M.C., G.G.S.).
- Montefiore Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (P.P.L., A.L.).
- Heart Center, Central Hospital of North Karelia, Joensuu, and the University of Eastern Finland (T.T.R.).
- Norfolk and Norwich University Hospital, United Kingdom (N.C., I.M., V.S.V., S.E.).
- Cardiovascular Department, Interventional Cardiology Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy (A.B., M. Galasso, D.M.).
ORCID-Profile: Mauro Gitto, Pier Pasquale Leone, Tuomas T Rissanen, Natasha Corballis, Andrea Buono, Vassilios S Vassiliou, Luigi Salemme, Mauro Chiarito, Michele Galasso, Michele Morosato, Kasper Kyhl, Giovanni Occhipinti, Guido Vellucci, Marcello Marchetta, Antonio Mangieri, Fabrizio Ugo, Gabriele Gasparini, Bernhard Reimers, Peter O' Kane, Giuseppe Massimo Sangiorgi, Giulio G Stefanini, Fernando Alfonso, Diego Arroyo, Manel Sabaté, Carlo Briguori, Tullio Tesorio, Diego Maffeo, Azeem Latib, Simon Eccleshall, Antonio Colombo
Zitieren
APA
Gitto, M., Leone, P. P., Rissanen, T. T., Corballis, N., Calamita, G., Tartaglia, F., Buono, A., Ferrone, M., Ielasi, A., Pismiankou, S., Rossi, M. L., Merinopoulos, I., Vassiliou, V. S., Salemme, L., Chiarito, M., Galasso, M., Morosato, M., Kyhl, K., Occhipinti, G., …, & Colombo, A. (2026). Clinical Outcomes of Bail-Out Stenting After Drug-Coated Balloon Angioplasty: The International Multicenter BAILOUT Registry. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.125.016461
Vancouver
Gitto M, Leone PP, Rissanen TT, Corballis N, Calamita G, Tartaglia F, et al. Clinical Outcomes of Bail-Out Stenting After Drug-Coated Balloon Angioplasty: The International Multicenter BAILOUT Registry. Circulation: Cardiovascular Interventions. 2026. doi:10.1161/circinterventions.125.016461
BibTeX
@article{Gitto2026,
author = {Gitto, Mauro and Leone, Pier Pasquale and Rissanen, Tuomas T and Corballis, Natasha and Calamita, Gianmaria and Tartaglia, Francesco and Buono, Andrea and Ferrone, Marco and Ielasi, Alfonso and Pismiankou, Siamion and Rossi, Marco Luciano and Merinopoulos, Ioannis and Vassiliou, Vassilios S and Salemme, Luigi and Chiarito, Mauro and Galasso, Michele and Morosato, Michele and Kyhl, Kasper and Occhipinti, Giovanni and Hinton, Jonathan and Bacci, Elodi and Vellucci, Guido and Marchetta, Marcello and De Micco, Francesca and Regazzoli, Damiano and Mangieri, Antonio and Johnson, Thomas and Ugo, Fabrizio and Gasparini, Gabriele and Reimers, Bernhard and Kane, Peter O' and Sangiorgi, Giuseppe Massimo and Stefanini, Giulio G and Galli, Stefano and Alfonso, Fernando and Arroyo, Diego and Sabaté, Manel and Briguori, Carlo and Tesorio, Tullio and Mashayekhi, Kambis and Maffeo, Diego and Latib, Azeem and Eccleshall, Simon and Colombo, Antonio},
title = {Clinical Outcomes of Bail-Out Stenting After Drug-Coated Balloon Angioplasty: The International Multicenter BAILOUT Registry},
journal = {Circulation: Cardiovascular Interventions},
year = {2026},
doi = {10.1161/circinterventions.125.016461}
}
EUVIMED